Total Payments
$94,233
2024 Payments
$41,359
Companies
31
Transactions
233
Medicare Patients
178
Medicare Billing
$16,348
Payment Breakdown by Category
Other$40,473 (42.9%)
Research$33,080 (35.1%)
Consulting$10,918 (11.6%)
Food & Beverage$5,962 (6.3%)
Travel$3,786 (4.0%)
Education$14.80 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $40,473 | 2 | 42.9% |
| Unspecified | $33,080 | 6 | 35.1% |
| Consulting Fee | $10,918 | 4 | 11.6% |
| Food and Beverage | $5,962 | 206 | 6.3% |
| Travel and Lodging | $3,786 | 13 | 4.0% |
| Education | $14.80 | 2 | 0.0% |
Payments by Type
General
$61,154
227 transactions
Research
$33,080
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CIPLA USA INC. | $40,473 | 2 | $0 (2024) |
| Circassia Pharmaceuticals Inc | $33,110 | 8 | $0 (2017) |
| GENZYME CORPORATION | $9,141 | 19 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,780 | 37 | $0 (2024) |
| Genentech USA, Inc. | $1,891 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,502 | 10 | $0 (2024) |
| ALK-Abello, Inc | $757.44 | 6 | $0 (2023) |
| GlaxoSmithKline, LLC. | $692.04 | 35 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $540.45 | 10 | $0 (2023) |
| PFIZER INC. | $369.94 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41,359 | 35 | CIPLA USA INC. ($40,473) |
| 2023 | $2,474 | 48 | AstraZeneca Pharmaceuticals LP ($1,565) |
| 2022 | $3,441 | 36 | AstraZeneca Pharmaceuticals LP ($1,643) |
| 2021 | $2,325 | 13 | Genentech USA, Inc. ($1,760) |
| 2020 | $265.94 | 13 | Teva Pharmaceuticals USA, Inc. ($71.50) |
| 2019 | $922.90 | 31 | PFIZER INC. ($227.87) |
| 2018 | $10,046 | 36 | GENZYME CORPORATION ($8,742) |
| 2017 | $33,399 | 21 | Circassia Pharmaceuticals Inc ($33,110) |
All Payment Transactions
233 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: RESPIRATORY | ||||||
| 11/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: BIOLOGIC | ||||||
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: Immunology | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $32.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: BIOLOGIC | ||||||
| 10/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $33.58 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | CIPLA USA INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $268.33 | General |
| 09/30/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Immunology and Neurology | ||||||
| 09/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Immunology and Neurology | ||||||
| 08/26/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $29.26 | General |
| Category: Oncology / Rare Diseases | ||||||
| 08/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/01/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $66.84 | General |
| 08/01/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: DERMATOLOGY | ||||||
| 07/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: RESPIRATORY | ||||||
| 07/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: RESPIRATORY | ||||||
| 04/12/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Immunology | ||||||
| 04/09/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Respiratory | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis | Circassia Pharmaceuticals Inc | $33,080 | 6 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 40 | 43 | $14,137 | $2,845 |
| 2022 | 2 | 34 | 38 | $12,354 | $2,496 |
| 2021 | 1 | 27 | 30 | $12,330 | $2,365 |
| 2020 | 4 | 77 | 903 | $44,570 | $8,643 |
Total Patients
178
Total Services
1,014
Medicare Billing
$16,348
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 30 | $12,330 | $2,604 | 21.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 12 | 13 | $1,807 | $240.40 | 13.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 26 | $10,686 | $2,229 | 20.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 11 | 12 | $1,668 | $266.55 | 16.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 30 | $12,330 | $2,365 | 19.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 33 | 41 | $14,979 | $3,301 | 22.0% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 17 | 833 | $16,879 | $3,062 | 18.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 15 | 15 | $8,889 | $1,620 | 18.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 14 | $3,823 | $658.93 | 17.2% |
About Dr. Alexander Greiner, M.D
Dr. Alexander Greiner, M.D is a Allergy & Immunology healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609801299.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexander Greiner, M.D has received a total of $94,233 in payments from pharmaceutical and medical device companies, with $41,359 received in 2024. These payments were reported across 233 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($40,473).
As a Medicare-enrolled provider, Greiner has provided services to 178 Medicare beneficiaries, totaling 1,014 services with total Medicare billing of $16,348. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Internal Medicine
- Location San Diego, CA
- Active Since 07/11/2006
- Last Updated 03/14/2016
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1609801299
Products in Payments
- NO PRODUCT DISCUSSED (Drug) $8,742
- Xolair (Biological) $1,891
- BREZTRI (Drug) $1,507
- Odactra (Drug) $686.76
- DUPIXENT (Biological) $671.21
- NUCALA (Biological) $348.23
- EUCRISA (Drug) $329.27
- TRELEGY ELLIPTA (Drug) $325.42
- FASENRA (Biological) $188.55
- FASENRA (Drug) $183.89
- Xhance (Drug) $182.60
- Hizentra (Biological) $180.98
- RINVOQ (Biological) $161.87
- AUVI-Q (Drug) $151.30
- Auvi-Q (Drug) $141.50
- ILARIS (Biological) $139.53
- CINQAIR (Biological) $129.99
- CUVITRU (Biological) $117.43
- Xembify (Biological) $114.00
- RUCONEST (Biological) $95.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in San Diego
Marc Riedl, Md, MD
Allergy & Immunology — Payments: $1.1M
Allergy & Immunology $1.1M
Dr. Andrew White, M.d, M.D
Allergy & Immunology — Payments: $646,235
Allergy & Immunology $646,235
Dr. Katharine Woessner, M.d, M.D
Allergy & Immunology — Payments: $587,522
Allergy & Immunology $587,522
Dr. Bruce Zuraw, Md, MD
Allergy & Immunology — Payments: $388,115
Allergy & Immunology $388,115
Bruce Prenner, Md, MD
Allergy & Immunology — Payments: $345,128
Allergy & Immunology $345,128
Brian Stone, M. D, M. D
Allergy & Immunology — Payments: $191,510
Allergy & Immunology $191,510